Tan, who was not involved in the orforglipron trials
Research demonstrates that approximately one-third of patients lose less than 0.5% body weight weekly during the first month of intensive behavioral treatment, with the majority of these individuals ultimately failing to achieve clinically meaningful results after six months
Once you have reached your weight loss goal with GLP-1 receptor agonists, you may wonder whether to continue the treatment
At Virta Health, we take a nutrition-first approach to metabolic health
GLP-1s are most well studied for weight loss (obesity) and blood sugar control (type 2 diabetes)
Conclusion Sulfur burps while on semaglutide can be an unpleasant side effect, but with the right dietary adjustments, lifestyle changes, and support, you can find relief and continue your health journey with confidence